The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.5% between 2025 ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

They developed a technique to detect diabetic retinopathy and other eye ailments long before any symptoms appear. The team focuses on identifying tiny molecular changes in tear fluid before any ...

It is currently scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy. The system, called the LumineticsCore ...

New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat non-proliferative diabetic retinopathy (NPDR). The multi-centre, placebo-controlled ...

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections currently not covered under Centre’s healthcare scheme.

Diabetic macular edema is a complication of diabetic retinopathy. Diabetic retinopathy develops when you have high blood glucose (the main sugar found in the blood) for an extended period ...